Respiratory effect of beta-blockers in people with asthma and cardiovascular disease: population-based nested case control study

BACKGROUND: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, safety concerns have caused heterogeneity in clinical guideline recommendations over the use of cardioselective beta-blockers in people with asthma and CVD, partly because risk in the general population...

Descripción completa

Detalles Bibliográficos
Autores principales: Morales, Daniel R., Lipworth, Brian J., Donnan, Peter T., Jackson, Cathy, Guthrie, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270217/
https://www.ncbi.nlm.nih.gov/pubmed/28126029
http://dx.doi.org/10.1186/s12916-017-0781-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270217/
https://www.ncbi.nlm.nih.gov/pubmed/28126029
http://dx.doi.org/10.1186/s12916-017-0781-0

Ejemplares similares